Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout
Conditions
Interventions
Allopurinol
Dotinurad
Locations
78
United States
Alabama Clinical Therapeutics
Birmingham, Alabama, United States
G & L Research
Foley, Alabama, United States
Arizona Arthritis & Rheumatology Associates (AARA) - Gilbert
Gilbert, Arizona, United States
Arizona Arthritis & Rheumatology Associates (AARA) - Glendale
Glendale, Arizona, United States
Arizona Arthritis & Rheumatology Associates (AARA) - Mesa
Mesa, Arizona, United States
Del Sol Research Management - Tucson East
Tucson, Arizona, United States
Start Date
August 4, 2025
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
April 22, 2026
Lead Sponsor
Crystalys Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions